Fosamax Cost in Virginia 2026: What You Will Actually Pay for Alendronate

What Does Fosamax Actually Cost in Virginia in 2026?

Generic alendronate 70 mg (once-weekly tablet) runs about $15 per month at most Virginia retail pharmacies in 2026. Brand-name Fosamax carries a manufacturer list price above $80 per month, though almost no patient pays that figure after insurance, discount cards, or manufacturer programs apply.

Alendronate belongs to the bisphosphonate drug class. The FDA first approved it in 1995 for postmenopausal osteoporosis, and the original Merck patent expired years ago, making generic versions broadly available [1]. Because generics are bioequivalent to brand-name Fosamax under FDA standards [2], most clinicians and insurers now default to the generic.

Price variation across Virginia is real. A GoodRx search run in early 2026 shows the 70 mg once-weekly tablet ranging from roughly $9 at Costco Pharmacy (Fairfax, VA) to $18 at some independent pharmacies. The single largest variable is which discount card or plan you present at the counter, not which pharmacy chain you choose.

Brand Fosamax is rarely dispensed today. If a Virginia pharmacy does dispense it without insurance, expect to pay $80 to $120 per month. Merck's patient-assistance program can reduce that cost significantly for qualifying patients, though most prescribers simply switch patients to the generic.

Alendronate's clinical value is well-documented. The Fracture Intervention Trial (FIT, JAMA 1998, N=2,027) showed that alendronate reduced the risk of hip fracture by 47% and clinical vertebral fracture by 55% in women with low femoral neck bone density over 36 months [3]. The American Association of Clinical Endocrinology (AACE) 2020 clinical practice guidelines list alendronate as a first-line agent for postmenopausal osteoporosis [4].

The Endocrine Society's 2019 pharmacological management guidelines state: "Bisphosphonates, including alendronate, are recommended as first-line therapy for most patients with osteoporosis given their proven antifracture efficacy and favorable safety profile" [5].

How Virginia Medicaid Covers Alendronate (Fosamax)

Virginia Medicaid covers alendronate, but a prior authorization (PA) step is required before the claim will process. The PA criteria generally require documented low bone density (T-score at or below -2.5) or a history of fragility fracture, consistent with USPSTF screening recommendations for women 65 and older [6].

Generic alendronate 70 mg tablets are on the Virginia Medicaid preferred drug list (PDL) as of 2026. Because the generic is preferred, the PA process is typically straightforward once your provider submits bone density results. Brand Fosamax is non-preferred and faces a more involved PA pathway; switching to generic almost always resolves coverage issues faster.

Medicaid managed-care plans operating in Virginia (Anthem HealthKeepers Plus, Molina Healthcare of Virginia, Optima Health Community Care, and others) all follow the state PDL, so the PA requirement applies regardless of which managed-care organization (MCO) you are enrolled with. Turnaround on PA requests is typically 3 to 5 business days under Virginia Medicaid regulations, though urgent requests can be processed within 24 hours.

If your PA is denied, your prescriber can request a Medicaid formulary exception or a clinical exception review. AACE guidelines support alendronate use in any patient with a FRAX 10-year major osteoporotic fracture probability at or above 20%, which can strengthen the clinical justification in an appeal [4].

The FDA-approved prescribing information for alendronate confirms the indication and dosing parameters your provider will cite in the PA: 70 mg once weekly orally for osteoporosis treatment, or 35 mg once weekly for prevention [1]. Having that documentation ready speeds the process.

Virginia Insurance Coverage: Commercial Plans, Medicare Part D, and Employer Plans

Most commercial health plans available in Virginia cover generic alendronate at a Tier 1 or Tier 2 copay, typically $0 to $15 per month with standard insurance. Medicare Part D coverage depends on the specific plan's formulary, but alendronate appears on the formulary of the majority of Part D plans sold in Virginia.

The Medicare Prescription Payment Plan (formerly the catastrophic cap) caps out-of-pocket drug costs at $2,000 per year starting in 2025 [7]. For a drug that costs $15 per month cash, most Part D enrollees will hit their deductible and then pay a small copay or nothing at all for alendronate.

Employer-sponsored plans in Virginia generally treat generic alendronate favorably. Large Virginia employers such as state government workers covered by COVA Care place generic bisphosphonates on their lowest cost-sharing tier. Federal employees in the DC-Virginia corridor using FEHB plans (Blue Cross Federal Employee Program, Aetna Federal, etc.) also typically see Tier 1 coverage.

The National Osteoporosis Foundation (now Bone Health and Osteoporosis Foundation) notes that treatment gaps often stem from cost concerns rather than true coverage gaps, particularly after patients reach Medicare age [8]. Knowing your exact copay before you leave the prescriber's office prevents the common scenario of abandoning a prescription at the pharmacy counter.

Virginia Cost Decision Framework: Which Path Is Cheapest for You?

| Patient Situation | Recommended Cost Path | Estimated Monthly Cost | |---|---|---| | Virginia Medicaid enrolled | Submit PA with bone density results; use generic | $0 after PA approval | | Medicare Part D enrolled | Confirm alendronate on your plan formulary | $0, $8 typical copay | | Uninsured, income-qualified | NeedyMeds or Merck patient assistance | $0, $5 | | Uninsured, not income-qualified | GoodRx or RxSaver coupon at Costco/Walmart | $9, $15 | | Employer insurance, generic preferred | Present insurance card; no coupon needed | $0, $15 copay | | Employer insurance, brand preferred | Ask prescriber to write "dispense as written" for generic | $0, $15 copay |

Is Compounded Alendronate Legal in Virginia?

Yes. Virginia-licensed 503A compounding pharmacies may legally prepare compounded alendronate for patients with a valid patient-specific prescription from a licensed prescriber [9]. Compounded alendronate at some clinics is provided at effectively $0 out-of-pocket when bundled with a clinical program, though this varies by pharmacy and prescriber arrangement.

The distinction between 503A and 503B pharmacies matters here. A 503A pharmacy compounds for individual patients on a prescription-by-prescription basis, which is the standard model for most compounding pharmacies in Virginia. A 503B outsourcing facility compounds in larger batches and can sell to healthcare providers without patient-specific prescriptions, but must register with the FDA [9].

Virginia's Board of Pharmacy regulates 503A pharmacies under Virginia Code Title 54.1, Chapter 34. Compounded alendronate is legal as long as the compounding pharmacist uses a USP-grade bulk active pharmaceutical ingredient (API) and the prescription is patient-specific. The FDA's guidance on compounding under the Federal Food, Drug, and Cosmetic Act clarifies that compounders may not compound copies of commercially available drugs unless there is a documented clinical difference, such as a formulation change needed for a patient with a specific swallowing disorder [9].

Practical implication: if you can swallow the standard 70 mg tablet, most compounding pharmacies will not prepare a compounded version unless your prescriber documents a clinical rationale. If you have a documented contraindication to excipients in the commercial tablet (such as lactose intolerance in a formulation context), a 503A pharmacy in Virginia can prepare an alternative.

The Endocrine Society's clinical practice guidelines confirm that oral alendronate at 70 mg once weekly is the standard-of-care reference formulation and that alternative delivery routes remain investigational [5]. Compounded liquid formulations exist in research settings but are not yet guideline-endorsed for routine use.

Telehealth Prescribing of Alendronate in Virginia

Virginia permits telehealth prescribing of alendronate. Virginia Code Section 54.1-2901 and related regulations allow licensed Virginia prescribers to conduct a telehealth evaluation and issue a valid prescription for non-controlled medications, including bisphosphonates, without an in-person visit [10].

A 2021 CMS interim rule that was made permanent extended telehealth flexibilities for Medicare beneficiaries, allowing dual-eligible patients in Virginia to receive osteoporosis management via telehealth and have prescriptions sent electronically to any Virginia pharmacy [11].

Before a prescriber will send an alendronate prescription via telehealth, you will typically need to share existing bone density (DEXA scan) results. Most Virginia telehealth platforms can retrieve records electronically or accept uploaded PDF reports. If you have not had a DEXA scan, the USPSTF recommends screening for all women at age 65 and for younger women whose 10-year fracture risk equals or exceeds that of a 65-year-old white woman using the FRAX tool [6].

HealthRX telehealth providers in Virginia can evaluate osteoporosis risk, review DEXA results, and prescribe alendronate or other bisphosphonates during a single video visit, typically within 48 hours of scheduling.

The Cheapest Ways to Get Alendronate in Virginia

Several overlapping programs can push your monthly cost below $10, and in some cases to zero.

GoodRx and RxSaver coupons. At Costco Pharmacy locations in Fairfax, Virginia Beach, or Richmond, GoodRx coupons bring a 12-tablet supply (three-month supply of 70 mg once-weekly tablets) to approximately $27 to $35, or $9 to $12 per month. RxSaver and Blink Health offer comparable pricing [12]. You cannot combine these coupons with insurance, so compare the coupon price against your copay before choosing.

Walmart $4 generic list. Alendronate 70 mg is on Walmart's $4 per month/$10 per 90 days generic list at Virginia Walmart pharmacy locations, making it one of the lowest reliably available cash prices without any coupon app required [13].

NeedyMeds patient assistance. NeedyMeds lists Merck's patient-assistance program for Fosamax and also state-specific resources for Virginia residents with low incomes. Income thresholds vary but typically apply to patients below 250% of the federal poverty level [14].

Virginia pharmaceutical assistance programs. Virginia does not operate a standalone state pharmaceutical assistance program (SPAP) for working-age adults the way some other states do, but Medicare Savings Programs (MSPs) can eliminate Part D premiums and cost-sharing for qualifying Virginia seniors, effectively bringing alendronate cost to $0 [15].

340B pricing. Virginia patients receiving care at federally qualified health centers (FQHCs), Ryan White HIV/AIDS clinics, or other 340B-covered entities may access alendronate at 340B pricing, which is substantially below retail. The Health Resources and Services Administration (HRSA) maintains the 340B program under Section 340B of the Public Health Service Act [16].

The American Association of Clinical Endocrinology published a 2020 clinical practice guideline noting that cost is one of the primary drivers of non-adherence to bisphosphonate therapy, and that generic alendronate's low price point makes it the preferred starting agent from a cost-effectiveness standpoint in most patients [4].

Alendronate Dosing, Administration, and Safety: What Virginia Patients Need to Know

Alendronate is taken as a 70 mg tablet once weekly for osteoporosis treatment, or 35 mg once weekly for prevention. Patients must swallow the tablet with a full glass (6 to 8 oz) of plain water at least 30 minutes before the first food, beverage, or other medication of the day, and must remain upright (sitting or standing) for at least 30 minutes afterward [1].

These instructions are not arbitrary. Alendronate can cause esophageal irritation or ulceration if it contacts the esophageal mucosa for extended periods. The FDA label warns that alendronate is contraindicated in patients with esophageal abnormalities that delay esophageal emptying (such as stricture or achalasia) and in patients who cannot stand or sit upright for at least 30 minutes [1].

Renal function affects prescribing decisions. The FDA label states that alendronate is not recommended for patients with a creatinine clearance below 35 mL/min [1]. The AACE 2020 guidelines align with this threshold and recommend switching to denosumab or another agent in patients with significant chronic kidney disease [4].

The FIT trial demonstrated a statistically significant reduction in hip fracture (3.2% alendronate vs. 6.0% placebo, relative risk 0.49, P<0.001) and clinical vertebral fracture (2.3% vs. 5.0%, relative risk 0.45, P<0.001) over 36 months of treatment [3]. Those numbers make alendronate one of the most rigorously validated osteoporosis treatments available, and they underpin its guideline-preferred status.

Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) are rare adverse events associated with long-term bisphosphonate use. A 2014 systematic review in the Annals of Internal Medicine estimated ONJ incidence at 1 in 10,000 to 1 in 100,000 patient-years of oral bisphosphonate use in the osteoporosis population [17]. The AACE guidelines recommend reassessing bisphosphonate therapy after 5 years of treatment and considering a drug holiday in lower-risk patients [4].

How the Merck Savings Card Works for Virginia Patients

Merck's savings card for Fosamax is designed for commercially insured patients and generally does not apply to Medicaid or Medicare beneficiaries. For eligible Virginia patients with commercial insurance, the card may reduce brand Fosamax copays to as low as $0 per month for a defined period, though Merck periodically revises the program terms.

The practical limitation: because generic alendronate costs $9 to $15 per month without any card, the Merck brand savings card rarely produces a lower out-of-pocket cost unless the patient has a documented clinical reason to use the brand product. Most Virginia prescribers write the generic by default.

To check current Merck savings program eligibility and terms, visit Merck's official patient assistance portal or ask the prescribing physician's office, which often has the most current program details on file.

For patients on Medicare Part D, the Extra Help (Low Income Subsidy) program through the Social Security Administration can eliminate or dramatically reduce alendronate cost-sharing. Virginia residents can apply through the SSA or through the Virginia Insurance Counseling and Assistance Program (VICAP), a free counseling service [15].

DEXA Scan Requirements and Monitoring in Virginia

Before starting alendronate, you need a baseline DEXA scan to confirm the diagnosis of osteoporosis or osteopenia and to document the T-score for insurance and Medicaid prior-authorization purposes. The USPSTF recommends DEXA screening starting at age 65 for all women and at younger ages for women with elevated fracture risk [6].

Medicare Part B covers DEXA scans once every 24 months for qualifying beneficiaries, and more frequently if medically necessary [11]. Virginia Medicaid covers DEXA scans when a PA is submitted with appropriate clinical documentation.

Follow-up DEXA scans are typically ordered every 1 to 2 years after starting alendronate to confirm bone density response. A 2019 study in the Journal of Bone and Mineral Research (N=14,049) found that patients who received follow-up DEXA monitoring had significantly higher rates of persistent bisphosphonate adherence compared with those who did not [18].

Virginia-Specific Pharmacy Access and Telehealth Workflow

Virginia has more than 2,000 licensed retail pharmacy locations, and alendronate 70 mg is stocked by virtually all of them. Mail-order pharmacy through your Part D or employer plan typically reduces the per-tablet cost further, often providing a 90-day supply for the price of a 60-day copay.

For Virginia telehealth patients, the standard workflow is:

1. Schedule a video visit with a Virginia-licensed prescriber (in-state licensure required per Virginia Code 54.1-2901).
2. Upload or share DEXA scan results before the appointment.
3. The prescriber electronically sends the prescription to your preferred Virginia pharmacy or to a mail-order pharmacy.
4. Present your GoodRx, insurance card, or 340B eligibility at pickup.

Controlled substances cannot be prescribed via telehealth without a prior in-person relationship in most circumstances, but alendronate is not a controlled substance, so no such restriction applies [10].